See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2014

A breakthrough in regenerative therapies for Heart Failure

Presenter: Frank Ahmann

January 21, 2014

Presentation Cell Therapy 2014

Novel Method of Cell Surface Modification

Presenter: Amit N. Patel

January 21, 2014

Presentation ISET 2014

Next Generation Stents: How Will They Be Used?

Presenter: Mahmood Razavi

January 21, 2014

Presentation Cell Therapy 2014

iPS derived human cardiac microtissues

Presenter: Gordana Vunjak-Novakovic

January 21, 2014

Presentation Cell Therapy 2014

Stem Cell & SDF-1/CXCR4 In Diabetes

Presenter: Feng Dong

January 21, 2014

Presentation ISET 2014

Single-Center Experience with Zilver PTX Drug-eluting Stent for Treatment of SFA Lesions and In-stent Re-Stenoses

Presenter: Melanie Schernthaner

January 20, 2014

Presentation

Immediate Results and Long-term Clinical Outcome of Patients with Unprotected Distal LM Restenosis

Presenter: Soledad Ojeda

January 20, 2014

Presentation ISET 2014

SMART™ Stent in the Treatment of Obstructive Superficial Femoral Artery Disease: Three-year Clinical Outcomes from the STROLL TRIAL

Presenter: Michael R. Jaff

January 20, 2014

Presentation ISET 2014

A Randomized Multicenter Clinical Trial of the Role of Renal Artery Stenting in Preventing Cardiovascular and Renal Endpoints: Results of the CORAL Study

Presenter: Christopher J. Cooper

January 20, 2014

Presentation ISET 2014

Safety and Efficacy of the EverFlex Stent in Long Complex SFA lesions: Sub-group Analysis of the DURABILITY II Study

Presenter: Mahmood Razavi

January 20, 2014

Advertisement

Slides

A breakthrough in regenerative therapies for Heart Failure

Novel Method of Cell Surface Modification

Next Generation Stents: How Will They Be Used?

iPS derived human cardiac microtissues

Stem Cell & SDF-1/CXCR4 In Diabetes

Single-Center Experience with Zilver PTX Drug-eluting Stent for Treatment of SFA Lesions and In-stent Re-Stenoses

Immediate Results and Long-term Clinical Outcome of Patients with Unprotected Distal LM Restenosis

SMART™ Stent in the Treatment of Obstructive Superficial Femoral Artery Disease: Three-year Clinical Outcomes from the STROLL TRIAL

A Randomized Multicenter Clinical Trial of the Role of Renal Artery Stenting in Preventing Cardiovascular and Renal Endpoints: Results of the CORAL Study

Safety and Efficacy of the EverFlex Stent in Long Complex SFA lesions: Sub-group Analysis of the DURABILITY II Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content